Sanofi news

€300M investment will expand production capabilities, add new labs, and increase floor space by 8000 m². The site will support a pipeline of biologics, including monoclonal antibodies.

Investing €200M, the company will build a fully automated cold warehouse and a multi-purpose building for medical tech, creating 500 jobs and expanding insulin production capabilities.

The new plant, costing EUR 30 million, will produce monoclonal antibodies for trials, doubling production capacity and enhancing the company's biopharmaceutical focus and market position.